Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMCITABINE vs GEMTUZUMAB OZOGAMICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEMCITABINE vs GEMTUZUMAB OZOGAMICIN: Safety Overview

Metric GEMCITABINE GEMTUZUMAB OZOGAMICIN
Total FAERS Reports 31,328 1,817
Deaths Reported 5,142 454
Death Rate 16.4% 25.0%
Hospitalizations 12,268 806
Average Patient Age 61.2 yrs 43.7 yrs
% Female Patients 48.4% 48.8%
FDA Approval Date Apr 11, 2016 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. Wyeth Pharmaceuticals LLC, a subsidia...
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription